This inventor holds 1 USPTO granted patent. Top assignee: Hamari Chemicals, Ltd.. Active years: 1984.
Company Filing History:
Years Active: 1984
Title: Magoichi Sako: Innovator in Pharmaceutical Chemistry
Introduction
Magoichi Sako is a notable inventor based in Seki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzothiazepine derivatives. His research has implications for various therapeutic applications.
Latest Patents
Magoichi Sako holds a patent for "1,5-Benzothiazepine derivatives and production thereof." This patent describes novel 1,5-benzothiazepine derivatives produced from corresponding 1,4-benzothiazine through a ring expansion reaction involving trimethylhalosilane, hydrogen peroxide, and water. The derivatives exhibit analgesic, antipyretic, and antiarrhythmic activities, showcasing their potential in medical applications.
Career Highlights
Sako is associated with Hamari Chemicals, Ltd., where he continues to advance his research in pharmaceutical innovations. His work has not only contributed to the scientific community but also to the development of new therapeutic agents.
Collaborations
Magoichi Sako has collaborated with notable colleagues such as Yoshifumi Maki and Naomichi Mitsumori. These collaborations have further enriched his research and development efforts in the field.
Conclusion
Magoichi Sako's contributions to the field of pharmaceutical chemistry through his innovative patents highlight his role as a significant inventor. His work continues to influence the development of new therapeutic agents, demonstrating the importance of innovation in healthcare.